These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 15339642

  • 1. Clearance of Alzheimer's Abeta peptide: the many roads to perdition.
    Tanzi RE, Moir RD, Wagner SL.
    Neuron; 2004 Sep 02; 43(5):605-8. PubMed ID: 15339642
    [Abstract] [Full Text] [Related]

  • 2. Metabolism of amyloid-beta peptide and Alzheimer's disease.
    Iwata N, Higuchi M, Saido TC.
    Pharmacol Ther; 2005 Nov 02; 108(2):129-48. PubMed ID: 16112736
    [Abstract] [Full Text] [Related]

  • 3. Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
    Wyss-Coray T.
    J Mol Neurosci; 2004 Nov 02; 24(1):149-53. PubMed ID: 15314264
    [Abstract] [Full Text] [Related]

  • 4. Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives.
    Wang YJ, Zhou HD, Zhou XF.
    Drug Discov Today; 2006 Oct 02; 11(19-20):931-8. PubMed ID: 16997144
    [Abstract] [Full Text] [Related]

  • 5. Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests.
    Bates KA, Verdile G, Li QX, Ames D, Hudson P, Masters CL, Martins RN.
    Mol Psychiatry; 2009 May 02; 14(5):469-86. PubMed ID: 18794889
    [Abstract] [Full Text] [Related]

  • 6. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes.
    Ito S, Ohtsuki S, Kamiie J, Nezu Y, Terasaki T.
    J Neurochem; 2007 Dec 02; 103(6):2482-90. PubMed ID: 17908238
    [Abstract] [Full Text] [Related]

  • 7. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
    Hong CS, Goins WF, Goss JR, Burton EA, Glorioso JC.
    Gene Ther; 2006 Jul 02; 13(14):1068-79. PubMed ID: 16541122
    [Abstract] [Full Text] [Related]

  • 8. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.
    Gouras GK, Almeida CG, Takahashi RH.
    Neurobiol Aging; 2005 Oct 02; 26(9):1235-44. PubMed ID: 16023263
    [Abstract] [Full Text] [Related]

  • 9. Alzheimer's disease: the cholesterol connection.
    Puglielli L, Tanzi RE, Kovacs DM.
    Nat Neurosci; 2003 Apr 02; 6(4):345-51. PubMed ID: 12658281
    [Abstract] [Full Text] [Related]

  • 10. Metabolic regulation of brain Abeta by neprilysin.
    Iwata N, Tsubuki S, Takaki Y, Shirotani K, Lu B, Gerard NP, Gerard C, Hama E, Lee HJ, Saido TC.
    Science; 2001 May 25; 292(5521):1550-2. PubMed ID: 11375493
    [Abstract] [Full Text] [Related]

  • 11. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE, Flaherty SL, Johanson CE, Duncan JA, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG.
    Acta Neuropathol; 2006 Oct 25; 112(4):405-15. PubMed ID: 16865397
    [Abstract] [Full Text] [Related]

  • 12. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide.
    Hama E, Saido TC.
    Med Hypotheses; 2005 Oct 25; 65(3):498-500. PubMed ID: 15921860
    [Abstract] [Full Text] [Related]

  • 13. LRP in amyloid-beta production and metabolism.
    Bu G, Cam J, Zerbinatti C.
    Ann N Y Acad Sci; 2006 Nov 25; 1086():35-53. PubMed ID: 17185504
    [Abstract] [Full Text] [Related]

  • 14. The role of intracellular amyloid beta in Alzheimer's disease.
    Li M, Chen L, Lee DH, Yu LC, Zhang Y.
    Prog Neurobiol; 2007 Oct 25; 83(3):131-9. PubMed ID: 17889422
    [Abstract] [Full Text] [Related]

  • 15. Amyloid-beta precursor protein mediates neuronal toxicity of amyloid beta through Go protein activation.
    Sola Vigo F, Kedikian G, Heredia L, Heredia F, Añel AD, Rosa AL, Lorenzo A.
    Neurobiol Aging; 2009 Sep 25; 30(9):1379-92. PubMed ID: 18187234
    [Abstract] [Full Text] [Related]

  • 16. Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention.
    Eckman EA, Eckman CB.
    Biochem Soc Trans; 2005 Nov 25; 33(Pt 5):1101-5. PubMed ID: 16246055
    [Abstract] [Full Text] [Related]

  • 17. Intraneuronal amyloid-beta plays a role in mediating the synergistic pathological effects of apoE4 and environmental stimulation.
    Levi O, Dolev I, Belinson H, Michaelson DM.
    J Neurochem; 2007 Nov 25; 103(3):1031-40. PubMed ID: 17666042
    [Abstract] [Full Text] [Related]

  • 18. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G, Bonavita V.
    Neurol Sci; 2007 Apr 25; 28(2):63-71. PubMed ID: 17464468
    [Abstract] [Full Text] [Related]

  • 19. Clearing amyloid through the blood-brain barrier.
    Zlokovic BV.
    J Neurochem; 2004 May 25; 89(4):807-11. PubMed ID: 15140180
    [Abstract] [Full Text] [Related]

  • 20. Amyloid beta-peptide levels in laser capture microdissected cornu ammonis 1 pyramidal neurons of Alzheimer's brain.
    Aoki M, Volkmann I, Tjernberg LO, Winblad B, Bogdanovic N.
    Neuroreport; 2008 Jul 16; 19(11):1085-9. PubMed ID: 18596605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.